Oncothyreon (ONTY) Tops Q3 EPS by 2c

Oncothyreon (NASDAQ: ONTY) reported Q3 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Oncothyreon (ONTY) click here.

You May Also Be Interested In

• Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
• Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition